Balance Sheet
Accounts PayablesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InnovAge Holding (INNV) Cash & Equivalents (2020 - 2025)

Historic Cash & Equivalents for InnovAge Holding (INNV) over the last 6 years, with Q4 2025 value amounting to $83.2 million.

  • InnovAge Holding's Cash & Equivalents rose 8056.99% to $83.2 million in Q4 2025 from the same period last year, while for Dec 2025 it was $83.2 million, marking a year-over-year increase of 8056.99%. This contributed to the annual value of $64.1 million for FY2025, which is 1261.37% up from last year.
  • Latest data reveals that InnovAge Holding reported Cash & Equivalents of $83.2 million as of Q4 2025, which was up 8056.99% from $67.1 million recorded in Q3 2025.
  • Over the past 5 years, InnovAge Holding's Cash & Equivalents peaked at $216.3 million during Q4 2021, and registered a low of $39.0 million during Q3 2024.
  • Over the past 5 years, InnovAge Holding's median Cash & Equivalents value was $93.9 million (recorded in 2022), while the average stood at $118.4 million.
  • Per our database at Business Quant, InnovAge Holding's Cash & Equivalents crashed by 5585.99% in 2024 and then surged by 8056.99% in 2025.
  • Over the past 5 years, InnovAge Holding's Cash & Equivalents (Quarter) stood at $216.3 million in 2021, then plummeted by 54.02% to $99.5 million in 2022, then tumbled by 45.63% to $54.1 million in 2023, then decreased by 14.8% to $46.1 million in 2024, then surged by 80.57% to $83.2 million in 2025.
  • Its Cash & Equivalents was $83.2 million in Q4 2025, compared to $67.1 million in Q3 2025 and $64.1 million in Q2 2025.